Appointment of Chief Financial Officer
Appointment of Chief Financial Officer
Perth, June 14, 2017 AEST (ABN Newswire) - MMJ PhytoTech Limited (ASX:MMJ) ("MMJ" or "the Company") is pleased to announce the appointment of Lisa Dea as Chief Financial Officer ("CFO") of the Company effective immediately. Ms. Dea has also been appointed CFO of Harvest One Cannabis Inc. ("Harvest One") (CVE:HVST), and replaces Mr Kwong Choo, who will be assuming a new role as Vice President Finance of Harvest One.

Ms. Dea has over 20 years of experience in the finance, securities and accounting fields, having been the CFO of several ASX, TSX and TSXV listed and dual listed companies including Kabuni Limited (ASX:WNH), El Tigre Silver Corporation (CVE:ELS) and Greenbriar Capital Corporation (CVE:GRB).

In these roles Ms. Dea was responsible for corporate strategy, all aspects of finance and legal, debt and capital market activities, internal and external public reporting, financial controls, processes and corporate governance.

Ms. Dea has been instrumental in helping several companies grow from the development stage to large-scale commercial operations. Prior to her time in industry, Lisa spent eleven years at Deloitte & Touche LLP, achieving the position of Senior Manager. Ms. Dea obtained her Chartered Accountants designation in 1997 and also holds a BComm from the University of British Columbia.

Managing Director of MMJ PhytoTech Andreas Gedeon, commented:

"We are very pleased to welcome someone of Lisa's caliber to the Company. Lisa brings a wealth of financial and strategic experience from several publically listed companies and will be extremely beneficial for the Company as we continue to execute on our growth strategy.

"Lisa is the final appointment at a corporate level and I am very confident we have assembled an extremely qualified executive team over the last few months to advance the Company's plans in the future."


About MMJ PhytoTech Ltd

Phytotech Medical ASX:PYL

In October 2017, MMJ PhytoTech Limited (ASX:MMJ) announced its strategy to become an incubator for strategic investments across regulated jurisdictions globally covering the entire cannabis value chain.

Following the successful listing of United Greeneries Holdings Ltd ("United Greeneries") and Satipharm AG ("Satipharm") on the TSX-V through Harvest One Cannabis Inc. (CVE:HVT), MMJ has focused on the identification of a number of independent strategic investment opportunities that have the potential to deliver significant value to the Company's shareholders.

MMJ is actively pursuing early stage opportunities with the ability to deliver significant future revenue and the opportunity to provide dramatic global synergistic value as regulatory frameworks in key international markets continue to evolve. MMJ is targeting the full range of emerging cannabis-related sectors including healthcare products, technology, infrastructure, logistics, processing, cultivation, equipment, R&D, hemp food products and retail.

MMJ currently holds an equity stake of 53,333,333 shares in Harvest One, 100% ownership of Israeli-based R&D division PhytoTech Therapeutics Limited ("PTL") and strategic holdings in e-Sense Lab Limited (ASX:ESE) and private Canadian-based company WeedMe Inc.

      


Contact

Andreas Gedeon
Managing Director
Phone: +1-250-713-6302
Email: agedeon@mmj.ca
www.mmjphytotech.com.au



Related Companies

MMJ PhytoTech Ltd   
Kabuni Ltd
Harvest One Cannabis Inc
Greenbriar Capital Corp
El Tigre Silver Corp

ABN Newswire This Page Viewed:  (Last 7 Days: 15) (Last 30 Days: 74) (Since Published: 3118) 
ANALYTICS: LOGIN HERE

MMJ PhytoTech Ltd NEWS: RECENT VISITS (28446)

Research Report

Social Media